施志勤
藥不藥理一下？NDMU 藥理學堂
閒聊藥理知識，科普分享藥理新知 Powered by Firstory Hosting
Nereden dinlenir?
Uygulamada podcast'ler Replaio Radio Çok yakındaPodcast'ler çok yakında uygulamaya geliyor. Şimdi yükle ve podcast'lere yepyeni bir bakışı ilk gören sen ol
Ücretsiz yükle
Android 5 Mn+ indirme · 4,8 puan
iOS yakında
Bölümler
EP16-生化解毒駭客戰 30.04.2026 24:39
留言告訴我你對這一集的想法： https://open.firstory.me/user/cmkv7qa0d034v01y476ovbpnq/comments Powered by Firstory Hosting
EP15-致命毒物的分子解毒術 28.04.2026 21:07
留言告訴我你對這一集的想法： https://open.firstory.me/user/cmkv7qa0d034v01y476ovbpnq/comments Powered by Firstory Hosting
EP14-心絞痛四藥機轉 27.04.2026 21:00
留言告訴我你對這一集的想法： https://open.firstory.me/user/cmkv7qa0d034v01y476ovbpnq/comments Powered by Firstory Hosting
EP13-急性心衰竭治療的鋼索遊戲 21.04.2026 18:32
留言告訴我你對這一集的想法： https://open.firstory.me/user/cmkv7qa0d034v01y476ovbpnq/comments Powered by Firstory Hosting
EP12-治療慢性心衰竭的化學駭客技術 21.04.2026 23:32
留言告訴我你對這一集的想法： https://open.firstory.me/user/cmkv7qa0d034v01y476ovbpnq/comments Powered by Firstory Hosting
EP11-氣喘藥物的微觀滅火機制 23.03.2026 25:35
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP10-支氣管擴張劑藥理機制 23.03.2026 18:51
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP09-駭入免疫系統撕下癌症偽裝 21.03.2026 21:19
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP08-器官移植抗排斥藥的五大機制 20.03.2026 21:34
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP07-凝血藥物的生死鋼索 31.01.2026 15:53
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP06-抗凝血劑的拆彈術 30.01.2026 14:22
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP05-拆解抗血小板藥物 29.01.2026 15:09
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP04-貧血真兇與治療 28.01.2026 17:04
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP03-降血脂藥物攻防戰 27.01.2026 15:42
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP02-心絞痛藥物運作原理 27.01.2026 17:22
留言告訴我你對這一集的想法： Powered by Firstory Hosting
EP01-打破心衰竭惡性循環 26.01.2026 16:31
留言告訴我你對這一集的想法： Powered by Firstory Hosting
Benzer podcast'ler
藥不藥理一下？NDMU 藥理學堂 podcast'ini Replaio'da dinle
Radyo ve podcast'ler tek uygulamada - ücretsiz, kayıt gerektirmez. Bugün yükle ve lansmanı kaçırma
Replaio bir podcast yayıncısı değildir; program adları, kapak görselleri ve ses içerikleri yazarlarına aittir ve herkese açık RSS beslemeleri aracılığıyla dağıtılır
